We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMO icon
3801
Imperial Oil
IMO
$60.4B
$615 ﹤0.01%
+10
New +$548
UXIN
3802
Uxin Ltd
UXIN
$282M
$572 ﹤0.01%
35
+5
+17% +$81
LGHL
3803
Lion Group Holding
LGHL
$831K
0
BNTC icon
3804
Benitec Biopharma
BNTC
$468M
$561 ﹤0.01%
186
PVLA
3805
Palvella Therapeutics
PVLA
$2.27B
$556 ﹤0.01%
23
CTRN icon
3806
Citi Trends
CTRN
$605M
$555 ﹤0.01%
25
-543
-96% -$11.1K
SPRO icon
3807
Spero Therapeutics
SPRO
$73M
$554 ﹤0.01%
458
XXII
3808
22nd Century Group
XXII
$1.48M
0
RJET
3809
Republic Airways Holdings
RJET
$1B
$539 ﹤0.01%
42
IPHA
3810
Innate Pharma
IPHA
$162M
$518 ﹤0.01%
205
PASG icon
3811
Passage Bio
PASG
$14.1M
$515 ﹤0.01%
39
MTA
3812
Metalla Royalty & Streaming
MTA
$818M
$489 ﹤0.01%
160
FRLN
3813
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$487 ﹤0.01%
+115
New +$455
SLAI
3814
DELISTED
SOLAI Ltd ADS
SLAI
$461 ﹤0.01%
24
+9
+60% +$199
UEIC icon
3815
Universal Electronics
UEIC
$61.3M
$452 ﹤0.01%
50
-1,367
-96% -$13.5K
DUO
3816
Fangdd Network Group
DUO
$24.3M
$442 ﹤0.01%
36
+31
+620% +$1.75K
QNCX icon
3817
Quince Therapeutics
QNCX
$29.5M
$441 ﹤0.01%
2
BB icon
3818
BlackBerry
BB
$5.26B
$423 ﹤0.01%
+90
New +$442
TXMD icon
3819
TherapeuticsMD
TXMD
$24M
$422 ﹤0.01%
140
CELU icon
3820
Celularity
CELU
$20.3M
$420 ﹤0.01%
189
-673
-78% -$2.42K
PCTI
3821
DELISTED
PCTEL, Inc. Common Stock
PCTI
$416 ﹤0.01%
100
DNN icon
3822
Denison Mines
DNN
$2.91B
$379 ﹤0.01%
+230
New +$318
ZME
3823
DELISTED
Zhangmen Education Inc. American Depositary Shares, each representing seventy-two (72) Class A Ordin
ZME
$377 ﹤0.01%
848
SOS
3824
SOS Limited
SOS
$14.6M
$374 ﹤0.01%
6
OBE
3825
Obsidian Energy
OBE
$662M
$369 ﹤0.01%
45

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.